Arno J. Kromminga
Mainz, RP, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform.
Journal: Frontiers in immunology
Published: February 21, 2025
Editorial: The immune response to therapeutic antibodies.
Journal: Frontiers in immunology
Published: January 01, 2025
Pharmacokinetic and pharmacodynamic similarity of biosimilar natalizumab (PB006) to its reference medicine: a randomized controlled trial.
Journal: Expert opinion on biological therapy
Published: December 04, 2023
When to Extend Monitoring of Anti-drug Antibodies for High-risk Biotherapeutics in Clinical Trials: an Opinion from the European Immunogenicity Platform.
Journal: The AAPS journal
Published: March 18, 2022
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation (Part 3 - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).
Journal: Bioanalysis
Published: February 03, 2021
Autoimmune Diseases Are Linked to Type IIb Autoimmune Chronic Spontaneous Urticaria.
Journal: Allergy, asthma & immunology research
Published: September 16, 2020
Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: October 24, 2019
Last Updated: 09/26/2026